Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality.
Front Immunol
; 13: 941663, 2022.
Article
in En
| MEDLINE
| ID: mdl-36032171
Key words
Full text:
1
Collection:
01-internacional
Health context:
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
COVID-19
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2022
Document type:
Article